201 related articles for article (PubMed ID: 33638948)
1. Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma.
Ma M; Chen Y; Chong X; Jiang F; Gao J; Shen L; Zhang C
Aging (Albany NY); 2021 Feb; 13(5):6999-7019. PubMed ID: 33638948
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Song Y; Yang K; Sun T; Tang R
BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L
Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of genomic and epigenetic regulation of endometrial cancer.
Zhong Q; Fan J; Chu H; Pang M; Li J; Fan Y; Liu P; Wu C; Qiao J; Li R; Hang J
Aging (Albany NY); 2020 May; 12(10):9260-9274. PubMed ID: 32412912
[TBL] [Abstract][Full Text] [Related]
5. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma.
Zheng M; Hu Y; Gou R; Wang J; Nie X; Li X; Liu Q; Liu J; Lin B
Aging (Albany NY); 2019 Jun; 11(12):4198-4215. PubMed ID: 31257224
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
Zhao Y; Gao Y; Xu X; Zhou J; Wang H
BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
[TBL] [Abstract][Full Text] [Related]
7. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D
Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
Kong L; Liu P; Zheng M; Xue B; Liang K; Tan X
Epigenomics; 2020 Mar; 12(6):507-524. PubMed ID: 32048534
[No Abstract] [Full Text] [Related]
9. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
[TBL] [Abstract][Full Text] [Related]
10. High Expression of miR-206 Predicts Adverse Outcomes: A Potential Therapeutic Target for Esophageal Cancer.
Du G; Zhou J; Cheng L; Ma X; Gui Y; Tan B
Comb Chem High Throughput Screen; 2019; 22(9):599-611. PubMed ID: 31648633
[TBL] [Abstract][Full Text] [Related]
11. Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling.
Wang J; Luo J; Sun Z; Sun F; Kong Z; Yu J
Medicine (Baltimore); 2020 Sep; 99(37):e22194. PubMed ID: 32925794
[TBL] [Abstract][Full Text] [Related]
12. Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme.
Ma Y; Xi Z
Oxid Med Cell Longev; 2022; 2022():9993319. PubMed ID: 36193073
[TBL] [Abstract][Full Text] [Related]
13. Integrated molecular analysis reveals complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas.
Peng D; Guo Y; Chen H; Zhao S; Washington K; Hu T; Shyr Y; El-Rifai W
Sci Rep; 2017 Jan; 7():40729. PubMed ID: 28102292
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer.
Woo HG; Choi JH; Yoon S; Jee BA; Cho EJ; Lee JH; Yu SJ; Yoon JH; Yi NJ; Lee KW; Suh KS; Kim YJ
Nat Commun; 2017 Oct; 8(1):839. PubMed ID: 29018224
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering.
Arora A; Olshen AB; Seshan VE; Shen R
Genome Med; 2020 Dec; 12(1):110. PubMed ID: 33272320
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma.
Ye C; Wang H; Li Z; Xia C; Yuan S; Yan R; Yang X; Ma T; Wen X; Yang D
Transl Androl Urol; 2021 Jul; 10(7):3030-3045. PubMed ID: 34430406
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of copy number and transcriptional expression profiles in esophageal cancer to identify a novel driver gene for therapy.
Dong G; Mao Q; Yu D; Zhang Y; Qiu M; Dong G; Chen Q; Xia W; Wang J; Xu L; Jiang F
Sci Rep; 2017 Feb; 7():42060. PubMed ID: 28169357
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Genomic and Epigenomic Analyses on Transcriptomic Regulation in Stomach Adenocarcinoma.
Chen J; Liu W; Du J; Wang P; Wang J; Ye K
Front Genet; 2021; 12():778095. PubMed ID: 35222516
[No Abstract] [Full Text] [Related]
19. Estimating gene expression from DNA methylation and copy number variation: A deep learning regression model for multi-omics integration.
Seal DB; Das V; Goswami S; De RK
Genomics; 2020 Jul; 112(4):2833-2841. PubMed ID: 32234433
[TBL] [Abstract][Full Text] [Related]
20. Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas.
Shen J; LeFave C; Sirosh I; Siegel AB; Tycko B; Santella RM
BMC Med Genomics; 2015 Jun; 8():28. PubMed ID: 26059414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]